Anti-interleukin-8 monoclonal antibody reduces free radical production and improves hemodynamics and survival rate in endotoxic shock in rabbits

Surgery

Volumn 122, Issue 1, 1997, Pages 60-68

  Carvalho, Gustavo L ^b   Wakabayashi, Go ^a   Shimazu, Motohide ^b   Karahashi, Tsuyoshi ^b   Yoshida, Masashi ^b   Yamamoto, Seiichiro ^b   Matsushima, Kouji ^b   Mukaida, Naofumi ^b   Clark, Burton D ^b   Takabayashi, Tsukasa ^b   Brandt, Carlos T ^b   Kitajima, Masaki ^b  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOTOXEMIA; HEMODYNAMICS; INFLAMMATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEPSIS; SEPTIC SHOCK; SURVIVAL; URINE VOLUME;

EID: 0030847254     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90265-8     Document Type: Article

References (49)

1. Members of American College of Chest Physicians/Society of Critical Care Medicine Concensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Concensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
2. Wherry JC, Pennington JE, Wenzel RP. Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies. Crit Care Med 1993;21:S436-40.
3. Herbert JC, O'Reilly M, Bednar MM. Modifying the host response to injury: the future of trauma care. Surg Clin North Am 1995;75:335-49.
4. Suffrendini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;318:1481-6.
5. Martich GD, Danner RL, Ceska M, Suffrendini AF. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effects of antiinflammatory agents. J Exp Med 1991;173:1021-4.
6. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
7. Downey GP, Waddell TK, Fukushima T, Sue AQA. Current techniques in cell and molecular biology. J Crit Care 1995;10:136-49.
8. Fahey TJ III, Yoshioka T, Shires GT, Fantini GA. The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin. Ann Surg 1996;223:63-9.
9. Tracey KJ, Cerami A. Tumor necrosis factor: an updated review of its biology. Crit Care Med 1993;21:S415-22.
10. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993;269:1829-935.
11. Fujishima S, Aikawa N. Neutrophil-mediated tissue injury and its modulation. Intensive Care Med 1995;21:277-85.
12. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994;56:559-64.
13. Porat R, Poutsiaka DD, Miller LC, Miller CL, Granowitz EV, Dinnarello CA. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 1994;6:2482-6.
14. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991;5:338-43.
15. Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992;89:1551-7.
16. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991;146:3478-82.
17. Kurdowska A, Mille EJ, Cohen AB. An anti-interleukin 8 monoclonal antibody that interferes with the binding of interleukin 8 to cellular receptors and the activation of human blood neutrophils. Hybridoma 1995;14:225-33.
18. Zwahlen R, Walz A, Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol 1993;34:27-42.
19. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E. Umberger R. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-73.
20. Lin RY, Astiz ME, Saxon JC; Saha DC, Rackow, EC, Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994;22:1595-602.
21. Endo S, Inada K, Ceska M, Takakuwa T, Yamada Y, Nakae H, et al. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflamm 1995;45:136-42.
22. Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M. Relationship between cytokines and leukotriene B4 in sepsis. Res Commun Chem Pathol Pharmacol 1994;83:151-6.
23. Vindenes H, Ulvestad E, Bjerknes R. Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis. J Trauma 1995;39:635-40.
24. Harada A, Sekido N, Kuno K, Akiyama M, Kasahara T, Nakanishi I, et al. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. Int Immunol 1993;5:681-90.
25. Akahoshi T, Endo H, Kondo H, Kashiwazaki S, Kasahara T, Mukaida N, et al. Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide and interleukin-1. Lymphokine Cytokine Research 1994;13:113-6.
26. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody. Nature 1993;365:654-7.
27. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995;96:107-16.
28. Wada T, Tomosugi N, Naito T, Yokoyama H, Kobayashi K, Harada A, et al. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 1994;180:1135-40.
29. Carvalho GL, Wakabayashi G, Shimazu M, Karahashi T, Yoshida M, Yamamoto S, et al. Rabbit liver microcirculation〈ems〉new intravital observation model using a liver exposure ring. Microcirculation Annual 1996;12:137-8.
30. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc Res 1992;26:48-57.
31. Jabs CM, Neglen P, Eklof B. Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock. Eur J Surg 1995;161:147-55.
32. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
33. Clark BD, Bedrosian J, Schindler R, Cominelli F, Cannon JG, Shaw AR, et al. Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 1991;71:2412-8.
34. Aiura K, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. Interleukin-1 (IL-1) receptor antagonist prevents staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits. Infect Immun 1993;61:3342-50.
35. Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF, Dinarello CA. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia: comparison to Escherichia coli. J Clin Invest 1991;87:1925-35.
36. Yoshida M, Fukumura D, Wakabayashi G, Otani Y, Oshima A, Shimazu M, et al. Gastric microcirculatory disturbance and behavior of leukocytes after thermal injury: intravital observation of arteriovenous shunting channels in the gastric submucosal layer. J Gastroenterol Hepatol 1995;10:365-70.
37. Yoshida M, Kitahora T, Wakabayashi G, Tashiro H, Ono H, Otani Y, et al. Active oxygen species in formation of acute gastric mucosal lesions induced by thermal injury in rats. Dig Dis Sci 1995;40:1306-10.
38. Trapp RG, Dawson-Saunders B. Basic and clinical biostatistics. 2nd ed. Norwalk: Lange Medical Books; 1994.
39. Pastor CM, Payen DM. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 1994;2:196-202.
40. Tracey KJ, Lowry SF, Fahey TJ III, Albert JD, Fong Y, Hesse D, et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987;164:415-22.
41. Van Zee KJ, Fischer E, Hawes AS, Hebert CA, Terrell TG, Baker JB, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992;148:1746-52.
42. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, Yoshinaga M, Neutrophil accumulation and activation by homologous IL-8 in rabbits: IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol 1995;154:5418-25.
43. Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL. Brief report: shock and multiple-organ dysfunction after self-administration of salmonella endotoxin. N Engl J Med 1993;328:1457-60.
44. Varani J, Ginsburg I, Schuger L, Gibbs DF, Bromberg J, Johnson KJ, et al. Endothelial cell killing by neutrophils: synergistic interaction of oxygen products and proteases. Am J Pathol 1989;135:435-8.
45. Tanaka H, Ogura H, Yokota J, Sugimoto H, Yoshioka T, Sugimoto T. Acceleration of Superoxide production from leukocytes in trauma patients. Ann Surg 1991;214:187-92.
46. Pesanti EL, Nugent KM. Modulation of pulmonary clearance of bacteria by antioxidants. Infect Immun 1985;48:57-61.
47. Henderson A, Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: potential new use for an old drug. Ann Pharmacother 1994;28:1086-8.
48. Drenth JP, Goertz J, Daha MR, van der Meer JW. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells. Immunology 1996;88:355-62.
49. Arend WP, Leung DY IgG induction of IL-1 receptor antagonist produciton by human monocytes. Immunol Rev 1994;139:71-8.